Tobias Grabe

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Replacement Therapy

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Tobias Grabe, Kirujan Jeyakumar, Janina Niggenaber, Tom Schulz, Sandra Koska, Silke Kleinbölting, Michael Edmund Beck, Matthias Philipp Müller, Daniel Rauh
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines. ACS medicinal chemistry letters 14 (5) (2023)
Tobias Grabe, Kirujan Jeyakumar, Janina Niggenaber, Tom Schulz, Sandra Koska, Silke Kleinbölting, Michael Edmund Beck, Matthias Philipp Müller, Daniel Rauh
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines. ACS medicinal chemistry letters 14 (5) (2023)